|
AU2007327011A1
|
|
Modulation of prostaglandin/cyclooxygenase metabolic pathways
|
|
GB0714500D0
|
|
composition and treatment
|
|
GB0623971D0
|
|
Modulation of prostaglandin/cyclooxygenase metabolic pathways
|
|
GB0524406D0
|
|
Thereapeutic uses of steroidal compounds
|
|
GB0523550D0
|
|
Therapeutic uses of steroidal compounds
|
|
GB0502267D0
|
|
Tricyclic cytoprotective compounds comprising an indole residue
|
|
GB0415348D0
|
|
Method of reducing levels of soluble amyloid peptides in the brain
|
|
GB0411696D0
|
|
Novel polyamines and their therapeutic use
|
|
US2007231373A1
|
|
Transdermal Steriod for Formulation
|
|
GB0119810D0
|
|
Prophylactic and therapeutic use of hydroxysteroids
|
|
GB0017060D0
|
|
Production, stabilisation and use of reduced forms of pharmaceutical compounds
|
|
GB0016022D0
|
|
Protection against neuronal damage using 7-hydroxyepiandrosterone
|
|
GB0016027D0
|
|
Protection against neuronal damage using 3-hydroxy-7 -hydroxy steroids and 3-oxo-7 -hydroxy steroids
|
